Advancing precision oncology in soft tissue sarcomas: The role of iTRAC in metastatic risk stratification and treatment personalization.

Adaptive AI-driven clinical decision-making in oncology through digital twins and large-scale imaging biomarkers. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

Whether clinicians are accurately diagnosing thyroid disease was at issue for Chinese researchers who demonstrated that adding subgroup differences according to age, sex, or race when testing for ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced major new features for the Guardant ...

Guardant Health, Inc. (NASDAQ:GH) has introduced major upgrades to its Guardant360 Liquid biopsy test, significantly ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

Conclusion: ROSE effectively differentiates benign from malignant lesions and accurately classifies SCLC and NSCLC during bronchoscopic biopsy. While useful for preliminary subtyping of SCC and AC, ...

I think that generic callable signatures are the only place where an unspecialized typevar can appear in a context where we need to do subtyping/assignability checks on it based on, effectively, a ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being ...